Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis
During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children du...
Uloženo v:
| Vydáno v: | Viruses Ročník 16; číslo 3; s. 429 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
MDPI AG
11.03.2024
MDPI |
| Témata: | |
| ISSN: | 1999-4915, 1999-4915 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020–2021) compared to the pre-pandemic (2015–2020) and post-lockdown (2021–2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0–18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran’s Q and I2 statistics, while publication bias was evaluated through funnel plots and Egger’s tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], p < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], p < 0.0001). Most pooled effect estimates exhibited significant heterogeneity (I2: 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks. |
|---|---|
| AbstractList | During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020-2021) compared to the pre-pandemic (2015-2020) and post-lockdown (2021-2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0-18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran's Q and I2 statistics, while publication bias was evaluated through funnel plots and Egger's tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], p < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], p < 0.0001). Most pooled effect estimates exhibited significant heterogeneity (I2: 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks.During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020-2021) compared to the pre-pandemic (2015-2020) and post-lockdown (2021-2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0-18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran's Q and I2 statistics, while publication bias was evaluated through funnel plots and Egger's tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], p < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], p < 0.0001). Most pooled effect estimates exhibited significant heterogeneity (I2: 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks. During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020–2021) compared to the pre-pandemic (2015–2020) and post-lockdown (2021–2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0–18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran’s Q and I2 statistics, while publication bias was evaluated through funnel plots and Egger’s tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], p < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], p < 0.0001). Most pooled effect estimates exhibited significant heterogeneity (I2: 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks. During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020–2021) compared to the pre-pandemic (2015–2020) and post-lockdown (2021–2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0–18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran’s Q and I² statistics, while publication bias was evaluated through funnel plots and Egger’s tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], p < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], p < 0.0001). Most pooled effect estimates exhibited significant heterogeneity (I²: 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks. During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020-2021) compared to the pre-pandemic (2015-2020) and post-lockdown (2021-2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0-18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran's Q and statistics, while publication bias was evaluated through funnel plots and Egger's tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], < 0.0001). Most pooled effect estimates exhibited significant heterogeneity ( : 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks. During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting the prevalence of respiratory syncytial virus (RSV). This review evaluated the impact of NPIs on RSV-related hospitalizations in children during the lockdown (2020–2021) compared to the pre-pandemic (2015–2020) and post-lockdown (2021–2022) periods. In this systematic review and meta-analysis, we searched through PubMed, Scopus, and Web of Science for studies published in English between 1 January 2015 and 31 December 2022. Additionally, we conducted hand searches of other records published between 1 January 2023 and 22 January 2024. Our target population was hospitalized children aged 0–18 years with RSV-related lower respiratory tract infections confirmed through immunofluorescence, antigen testing, or molecular assays. We focused on peer-reviewed observational studies, analyzing the primary outcome of pooled RSV prevalence. A generalized linear mixed model with a random-effects model was utilized to pool each RSV prevalence. Heterogeneity was assessed using Cochran’s Q and I[sup.2] statistics, while publication bias was evaluated through funnel plots and Egger’s tests. We identified and analyzed 5815 publications and included 112 studies with 308,985 participants. Notably, RSV prevalence was significantly lower during the lockdown period (5.03% [95% CI: 2.67; 9.28]) than during the pre-pandemic period (25.60% [95% CI: 22.57; 28.88], p < 0.0001). However, RSV prevalence increased notably in the post-lockdown period after the relaxation of COVID-19 prevention measures (42.02% [95% CI: 31.49; 53.33] vs. 5.03% [95% CI: 2.67; 9.28], p < 0.0001). Most pooled effect estimates exhibited significant heterogeneity (I[sup.2] : 91.2% to 99.3%). Our findings emphasize the effectiveness of NPIs in reducing RSV transmission. NPIs should be considered significant public health measures to address RSV outbreaks. |
| Audience | Academic |
| Author | Noyola, Daniel E. Esparza-Miranda, Luis A. Rivera-Alfaro, Gerardo Leija-Martínez, José J. |
| AuthorAffiliation | 1 Research Center in Health Sciences and Biomedicine (CICSaB), Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico; jesus.leija@uaslp.mx (J.J.L.-M.); a250764@alumnos.uaslp.mx (L.A.E.-M.); a238871@alumnos.uaslp.mx (G.R.-A.) 2 Microbiology Department, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico |
| AuthorAffiliation_xml | – name: 1 Research Center in Health Sciences and Biomedicine (CICSaB), Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico; jesus.leija@uaslp.mx (J.J.L.-M.); a250764@alumnos.uaslp.mx (L.A.E.-M.); a238871@alumnos.uaslp.mx (G.R.-A.) – name: 2 Microbiology Department, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico |
| Author_xml | – sequence: 1 givenname: José J. orcidid: 0000-0002-7178-1786 surname: Leija-Martínez fullname: Leija-Martínez, José J. – sequence: 2 givenname: Luis A. orcidid: 0009-0002-2233-6106 surname: Esparza-Miranda fullname: Esparza-Miranda, Luis A. – sequence: 3 givenname: Gerardo orcidid: 0000-0002-0439-5463 surname: Rivera-Alfaro fullname: Rivera-Alfaro, Gerardo – sequence: 4 givenname: Daniel E. orcidid: 0000-0002-4840-6742 surname: Noyola fullname: Noyola, Daniel E. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38543794$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFk8tuEzEUhkeoiF5gwQsgS2xgkdYeey5mg6JwaaRAKyjdjk48x4mjGTvYM6nCy_IqOEkpTVUJzcIjn-_8_nX8-zg5sM5ikrxk9JRzSc9WLKecilQ-SY6YlHIgJMsO7v0fJschLCjNc0mLZ8khLzPBCymOkt_jdgmqI06Tr84u5-BbUNh3RkFDxrZDv0LbGWcDqXtv7Ix0cySji-vxhwGT5BJsja1RxNlt4dLjChq0CjeK3zAsjYfO-TX5vrZq3Zmoem18H4ix5NzFcgeN-YU1Gc1NU3u05MZ0czJxN-j3-q_8xubYalRbO-_IMGqGDluIZiO6MnhDoh3yBTsYDC0062DC8-Sphibgi9v1JPnx6ePV6Hwwufg8Hg0nA5UVtBukWqDQgnMEFDTHKdM5Kskp4xnwrKxxWqQUaDatCy60Kspacc1lXoOGKU_5STLe6dYOFtXSmxb8unJgqu2G87MKfDTaYKURNcgMRVkLUUAKGS-VyHOaT7XMgUat9zutZT9tsVbxAjw0e6L7FWvm1cytKkZlIVgmo8KbWwXvfvYYuqo1QWHTgEXXh4qzjLM8pWn2f5QyQWmkeURfP0AXrvdx0BuKcsloIct_1CwGoTJWu-hRbUSrYVGWaZbFwyN1-ggVv22cYry1ift7Da_uD-VuGn-jHIG3O0B5F4JHfYcwWm2eSXX3TCJ79oBVMYibXEUXpnmk4w_4zRaQ |
| CitedBy_id | crossref_primary_10_3390_v16091394 crossref_primary_10_3390_jcm14041387 crossref_primary_10_1007_s12560_024_09618_y crossref_primary_10_1002_ppul_27469 crossref_primary_10_1002_jmv_70348 crossref_primary_10_1111_dmcn_16388 crossref_primary_10_1038_s41598_024_82660_9 crossref_primary_10_3390_v17050651 crossref_primary_10_1007_s10096_025_05133_5 crossref_primary_10_3390_v16121917 crossref_primary_10_1111_jpc_16643 crossref_primary_10_1111_tmi_14125 crossref_primary_10_3947_ic_2024_0122 |
| Cites_doi | 10.1093/infdis/jiy056 10.1136/bmj.j4008 10.3390/children8070556 10.1111/irv.12584 10.1016/S0140-6736(22)00478-0 10.1371/journal.pmed.1003583 10.1093/cid/ciab311 10.1016/S1473-3099(22)00544-8 10.2139/ssrn.3795266 10.1016/S2352-4642(21)00333-3 10.1016/j.jped.2022.03.003 10.1016/S2352-4642(22)00371-6 10.1016/j.envint.2020.105730 10.1016/S1473-3099(22)00763-0 10.3201/eid2802.211727 10.3390/v15020280 10.1136/bmj.327.7414.557 10.1016/S2214-109X(19)30264-5 10.7189/jogh.13.04001 10.1371/journal.pone.0242302 10.3390/ijerph20075223 10.1093/infdis/jiac192 10.3390/ijerph18189550 10.1016/S2352-4642(22)00092-X 10.1186/s12916-020-01872-8 10.1093/infdis/jiac150 10.1136/archdischild-2021-323375 10.1007/s00430-021-00720-7 10.3389/fped.2021.721005 10.2196/42781 10.1503/cmaj.210919 10.1093/infdis/jiad185 10.1016/j.jclinepi.2011.11.014 10.1038/s41597-021-00878-y 10.1111/irv.12998 10.1093/jalm/jfac058 10.1371/journal.pone.0249992 10.3389/fped.2021.740785 10.1017/ice.2021.430 10.1016/S1473-3099(22)00525-4 10.1093/cid/ciab240 10.1016/j.eclinm.2023.102089 10.1097/EDE.0000000000001232 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2024 MDPI AG 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 by the authors. 2024 |
| Copyright_xml | – notice: COPYRIGHT 2024 MDPI AG – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 by the authors. 2024 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 7S9 L.6 5PM DOA |
| DOI | 10.3390/v16030429 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef AGRICOLA MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology Public Health Statistics |
| EISSN | 1999-4915 |
| ExternalDocumentID | oai_doaj_org_article_feefa95e48d447a2a538c46606bf96a0 PMC10974159 A788255153 38543794 10_3390_v16030429 |
| Genre | Meta-Analysis Review Systematic Review Journal Article |
| GeographicLocations | Mexico |
| GeographicLocations_xml | – name: Mexico |
| GroupedDBID | --- 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACUHS AFFHD AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK E3Z EBD ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M48 M7P MODMG M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO RPM TR2 TUS UKHRP 3V. ALIPV CGR CUY CVF ECM EIF ISR NPM 7U9 7XB 8FK AZQEC DWQXO GNUQQ H94 K9. PKEHL PQEST PQUKI 7X8 ESTFP PUEGO 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c570t-2f4e4f433eae406eb1f6ec930135a358deb720a05bd734fc78dc3f396dafab323 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 15 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001193433900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1999-4915 |
| IngestDate | Tue Oct 14 19:05:44 EDT 2025 Tue Nov 04 02:05:48 EST 2025 Sun Sep 28 04:23:45 EDT 2025 Sat Sep 27 19:07:57 EDT 2025 Sat Nov 29 14:45:42 EST 2025 Sat Nov 29 14:08:46 EST 2025 Sat Nov 29 10:46:18 EST 2025 Wed Feb 19 02:08:28 EST 2025 Sat Nov 29 07:13:46 EST 2025 Tue Nov 18 21:26:47 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | COVID-19 lockdown SARS-CoV-2 respiratory tract infection respiratory syncytial virus nonpharmaceutical interventions |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c570t-2f4e4f433eae406eb1f6ec930135a358deb720a05bd734fc78dc3f396dafab323 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-7178-1786 0000-0002-4840-6742 0000-0002-0439-5463 0009-0002-2233-6106 |
| OpenAccessLink | https://www.proquest.com/docview/3003910798?pq-origsite=%requestingapplication% |
| PMID | 38543794 |
| PQID | 3003910798 |
| PQPubID | 2032319 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_feefa95e48d447a2a538c46606bf96a0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10974159 proquest_miscellaneous_3153162025 proquest_miscellaneous_3014003163 proquest_journals_3003910798 gale_infotracmisc_A788255153 gale_infotracacademiconefile_A788255153 pubmed_primary_38543794 crossref_primary_10_3390_v16030429 crossref_citationtrail_10_3390_v16030429 |
| PublicationCentury | 2000 |
| PublicationDate | 20240311 |
| PublicationDateYYYYMMDD | 2024-03-11 |
| PublicationDate_xml | – month: 3 year: 2024 text: 20240311 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Viruses |
| PublicationTitleAlternate | Viruses |
| PublicationYear | 2024 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Groves (ref_37) 2021; 1 Morawska (ref_8) 2020; 139 Nygaard (ref_48) 2023; 7 ref_14 ref_13 ref_12 Ippolito (ref_24) 2021; 9 Bernstein (ref_44) 2023; 8 Pratt (ref_27) 2022; 6 Varela (ref_20) 2022; 98 ref_15 Lin (ref_18) 2020; 31 Suryanarayanan (ref_42) 2021; 8 Reicherz (ref_32) 2022; 226 Higgins (ref_19) 2003; 327 ref_25 Rodgers (ref_29) 2021; 73 Song (ref_23) 2022; 43 Regassa (ref_26) 2023; 13 ref_28 Reicherz (ref_35) 2023; 61 Hoy (ref_16) 2012; 65 Ravkin (ref_7) 2022; 24 Billard (ref_30) 2023; 23 Li (ref_1) 2022; 399 Bardsley (ref_5) 2023; 23 Stamm (ref_36) 2021; 210 Piret (ref_34) 2022; 28 Billard (ref_40) 2022; 16 ref_38 Onwuchekwa (ref_43) 2023; 228 Lucion (ref_21) 2022; 120 Foley (ref_10) 2022; 107 Kenmoe (ref_47) 2018; 12 Lavoie (ref_9) 2021; 193 Hatter (ref_31) 2021; 5 ref_46 ref_45 Sly (ref_2) 2018; 217 ref_41 Johannesen (ref_39) 2022; 226 McNab (ref_11) 2021; 73 Li (ref_3) 2019; 7 ref_49 Voitl (ref_22) 2021; 9 Schepp (ref_33) 2023; 23 ref_4 ref_6 Shea (ref_17) 2017; 358 |
| References_xml | – volume: 217 start-page: 1356 year: 2018 ident: ref_2 article-title: Respiratory Syncytial Virus Seasonality: A Global Overview publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiy056 – volume: 358 start-page: j4008 year: 2017 ident: ref_17 article-title: AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-Randomised Studies of Healthcare Interventions, or Both publication-title: BMJ doi: 10.1136/bmj.j4008 – ident: ref_25 doi: 10.3390/children8070556 – volume: 12 start-page: 793 year: 2018 ident: ref_47 article-title: Prevalence of Human Respiratory Syncytial Virus Infection in People with Acute Respiratory Tract Infections in Africa: A Systematic Review and Meta-analysis publication-title: Influenza Other Respir. Viruses doi: 10.1111/irv.12584 – volume: 399 start-page: 2047 year: 2022 ident: ref_1 article-title: Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger Than 5 Years in 2019: A Systematic Analysis publication-title: Lancet doi: 10.1016/S0140-6736(22)00478-0 – ident: ref_13 doi: 10.1371/journal.pmed.1003583 – volume: 73 start-page: S100 year: 2021 ident: ref_29 article-title: Changes in Seasonal Respiratory Illnesses in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciab311 – volume: 23 start-page: 3 year: 2023 ident: ref_30 article-title: Quantifying the RSV Immunity Debt Following COVID-19: A Public Health Matter publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(22)00544-8 – ident: ref_38 doi: 10.2139/ssrn.3795266 – volume: 5 start-page: e44 year: 2021 ident: ref_31 article-title: Respiratory Syncytial Virus: Paying the Immunity Debt with Interest publication-title: Lancet Child. Adolesc. Health doi: 10.1016/S2352-4642(21)00333-3 – volume: 98 start-page: 579 year: 2022 ident: ref_20 article-title: Rhinovirus as the Main Co-Circulating Virus During the COVID-19 Pandemic in Children publication-title: J. Pediatr. doi: 10.1016/j.jped.2022.03.003 – volume: 7 start-page: 171 year: 2023 ident: ref_48 article-title: Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: A Danish nationwide cohort study publication-title: Lancet Child. Adolesc. Health doi: 10.1016/S2352-4642(22)00371-6 – volume: 139 start-page: 105730 year: 2020 ident: ref_8 article-title: Airborne Transmission of SARS-CoV-2: The World Should Face the Reality publication-title: Environ. Int. doi: 10.1016/j.envint.2020.105730 – ident: ref_4 – volume: 23 start-page: 23 year: 2023 ident: ref_33 article-title: Decline of RSV-Specific Antibodies During the COVID-19 Pandemic publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(22)00763-0 – volume: 28 start-page: 273 year: 2022 ident: ref_34 article-title: Viral Interference between Respiratory Viruses publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2802.211727 – ident: ref_6 doi: 10.3390/v15020280 – volume: 327 start-page: 557 year: 2003 ident: ref_19 article-title: Measuring Inconsistency in Meta-Analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 7 start-page: e1031 year: 2019 ident: ref_3 article-title: Global Patterns in Monthly Activity of Influenza Virus, Respiratory Syncytial Virus, Parainfluenza Virus, and Metapneumovirus: A Systematic Analysis publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(19)30264-5 – volume: 13 start-page: 04001 year: 2023 ident: ref_26 article-title: Molecular Epidemiology of Respiratory Syncytial Virus in Children with Acute Respiratory Illnesses in Africa: A Systematic Review and Meta-Analysis publication-title: J. Glob. Health doi: 10.7189/jogh.13.04001 – ident: ref_45 doi: 10.1371/journal.pone.0242302 – ident: ref_49 doi: 10.3390/ijerph20075223 – volume: 226 start-page: 2064 year: 2022 ident: ref_32 article-title: Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 Pandemic publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiac192 – ident: ref_28 doi: 10.3390/ijerph18189550 – volume: 6 start-page: 555 year: 2022 ident: ref_27 article-title: Prevalence of Respiratory Viruses in Community-Acquired Pneumonia in Children: A Systematic Review and Meta-Analysis publication-title: Lancet Child. Adolesc. Health doi: 10.1016/S2352-4642(22)00092-X – volume: 1 start-page: 100015 year: 2021 ident: ref_37 article-title: The Impact of the COVID-19 Pandemic on Influenza, Respiratory Syncytial Virus, and Other Seasonal Respiratory Virus Circulation in Canada: A Population-Based Study publication-title: Lancet Reg. Health Am. – ident: ref_41 doi: 10.1186/s12916-020-01872-8 – volume: 226 start-page: S29 year: 2022 ident: ref_39 article-title: Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiac150 – volume: 107 start-page: e7 year: 2022 ident: ref_10 article-title: Examining the Interseasonal Resurgence of Respiratory Syncytial Virus in Western Australia publication-title: Arch. Dis. Child. doi: 10.1136/archdischild-2021-323375 – volume: 210 start-page: 277 year: 2021 ident: ref_36 article-title: Influenza and RSV Incidence during COVID-19 Pandemic—An Observational Study from In-Hospital Point-of-Care Testing publication-title: Med. Microbiol. Immunol. doi: 10.1007/s00430-021-00720-7 – ident: ref_14 – volume: 9 start-page: 721005 year: 2021 ident: ref_24 article-title: Disappearance of Seasonal Respiratory Viruses in Children Under Two Years Old During COVID-19 Pandemic: A Monocentric Retrospective Study in Milan, Italy publication-title: Front. Pediatr. doi: 10.3389/fped.2021.721005 – volume: 24 start-page: e42781 year: 2022 ident: ref_7 article-title: The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data publication-title: J. Med. Internet Res. doi: 10.2196/42781 – volume: 193 start-page: E1140 year: 2021 ident: ref_9 article-title: Potential Resurgence of Respiratory Syncytial Virus in Canada publication-title: CMAJ doi: 10.1503/cmaj.210919 – volume: 228 start-page: 1516 year: 2023 ident: ref_43 article-title: Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiad185 – volume: 65 start-page: 934 year: 2012 ident: ref_16 article-title: Assessing Risk of Bias in Prevalence Studies: Modification of an Existing Tool and Evidence of Interrater Agreement publication-title: J. Clin. Epidemiol. doi: 10.1016/j.jclinepi.2011.11.014 – volume: 8 start-page: 94 year: 2021 ident: ref_42 article-title: AI-Assisted Tracking of Worldwide Non-Pharmaceutical Interventions for COVID-19 publication-title: Sci. Data. doi: 10.1038/s41597-021-00878-y – volume: 16 start-page: 926 year: 2022 ident: ref_40 article-title: International Changes in Respiratory Syncytial Virus (RSV) Epidemiology during the COVID-19 Pandemic: Association with School Closures publication-title: Influenza Other Respir. Viruses. doi: 10.1111/irv.12998 – volume: 120 start-page: 99 year: 2022 ident: ref_21 article-title: Impact of COVID-19 on the Circulation of Respiratory Viruses in a Children’s Hospital: An Expected Absence publication-title: Arch. Argent. Pediatr. – volume: 8 start-page: 353 year: 2023 ident: ref_44 article-title: Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era publication-title: J. Appl. Lab. Med. doi: 10.1093/jalm/jfac058 – ident: ref_46 doi: 10.1371/journal.pone.0249992 – ident: ref_12 – volume: 9 start-page: 740785 year: 2021 ident: ref_22 article-title: Respiratory Infections in Children During a Covid-19 Pandemic Winter publication-title: Front. Pediatr. doi: 10.3389/fped.2021.740785 – volume: 43 start-page: 1454 year: 2022 ident: ref_23 article-title: Common Seasonal Respiratory Viral Infections in Children Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic publication-title: Infect. Control Hosp. Epidemiol. doi: 10.1017/ice.2021.430 – volume: 23 start-page: 56 year: 2023 ident: ref_5 article-title: Epidemiology of Respiratory Syncytial Virus in Children Younger than 5 Years in England during the COVID-19 Pandemic, Measured by Laboratory, Clinical, and Syndromic Surveillance: A Retrospective Observational Study publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(22)00525-4 – volume: 73 start-page: 2365 year: 2021 ident: ref_11 article-title: Changing Epidemiology of Respiratory Syncytial Virus in Australia-Delayed Re-Emergence in Victoria Compared to Western Australia/New South Wales (WA/NSW) after Prolonged Lock-Down for Coronavirus Disease 2019 (COVID-19) publication-title: Clin. Infect Dis. doi: 10.1093/cid/ciab240 – volume: 61 start-page: 102089 year: 2023 ident: ref_35 article-title: Why Has the Epidemiology of RSV Changed During the COVID-19 Pandemic? publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2023.102089 – ident: ref_15 – volume: 31 start-page: 713 year: 2020 ident: ref_18 article-title: Meta-Analysis of Proportions Using Generalized Linear Mixed Models publication-title: Epidemiology doi: 10.1097/EDE.0000000000001232 |
| SSID | ssj0066907 |
| Score | 2.4431136 |
| SecondaryResourceType | review_article |
| Snippet | During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented in order to control the transmission of SARS-CoV-2, potentially affecting... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 429 |
| SubjectTerms | Antigens Bias Care and treatment Child Child, Hospitalized Children Communicable Disease Control COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 infection Data collection Demographic aspects Diagnosis Disease transmission Epidemics fluorescent antibody technique Hospitalization Humans Immunofluorescence Influence lockdown Meta-analysis Mexico nonpharmaceutical interventions Nosocomial infections Pandemics Performance evaluation Prevalence Public health Respiratory distress syndrome Respiratory syncytial virus Respiratory syncytial virus infection Respiratory Syncytial Virus Infections - epidemiology Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Virus, Human respiratory system Respiratory tract infection Respiratory Tract Infections - epidemiology Respiratory Tract Infections - prevention & control Reviews SARS-CoV-2 Seasons Severe acute respiratory syndrome coronavirus 2 Statistical analysis statistical models statistics Systematic Review Winter |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9QwDI_QNCReEP8pDGQQErxUa5s0bXk7DiZOGsfExmlvVZomWqWtN13vJm1flq-C3fRKKxC88Nq4rZM4jp3YPzP2BheYzIpU-VYW2hcmiv0ssKVvk1TpsJRctom0i8NkPk9PT7OjQakviglz8MBu4PatMVZlsRFpKUSiIoUrVAuJdndhM6labx2tnq0z5XSwJJ_P4QhxdOr3r6iYMqne0e7TgvT_rooHe9E4TnKw8RzcY3c7ixEmjtP77JapH7Dbrobk9UP2Y9bmOcLSwnxZX54Nj6hhNohobMClJAKafDD9uph99MMMjugQ-aLSsKzbBoJ0Um0iEn3x26-LeDi-Rj2M-uAcFtVq00BVw7boSHVjSph2aeFAR7twSNXXRu-fUD4WcuSCv-rmPUzguMeRBndJAcgOfDFr5W_RUh6x7wefTqaf_a5qg6_jJFj7kRVGWMG5UQatBdwLrDQ6Q0XCY8XjtDRFEgUqiIsy4cLqJC01tzyTpbKq4BF_zHbqZW2eMgiNNGlJLk9ghNalkgYNVroojQsCzfHYu-1s5rqDNKfKGuc5ujY08Xk_8R573ZNeOhyPPxF9IJHoCQh6u32AApl3Apn_SyA99pYEKicFgcxo1eU5YJcIaiufJOjUoJ0aI_t7I0pc2HrcvBXJvFMsTc5bSP8gyVKPveqb6U0KlqvNckM06DWjspb8LzT4g1BGaPF67ImT8r7bPI0JpVJ4LB3J_2hcxi11ddZCk1M8A5qE2bP_MZLP2R1kUFDEXxjusZ31amNesF19ta6a1ct2wf8Eqnpgdg priority: 102 providerName: Directory of Open Access Journals |
| Title | Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38543794 https://www.proquest.com/docview/3003910798 https://www.proquest.com/docview/3014003163 https://www.proquest.com/docview/3153162025 https://pubmed.ncbi.nlm.nih.gov/PMC10974159 https://doaj.org/article/feefa95e48d447a2a538c46606bf96a0 |
| Volume | 16 |
| WOSCitedRecordID | wos001193433900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYBhIS4mN8BUZlEBK8REvixEl4QV3ZRKWtRNuYylPkODarNJLStJPGP8u_wp3zsUagvfDSh9hJLtX557vz3e8IeQsLjMdZJGzNM2n7ygvs2NG5rcNISDfnjJtC2rPDcDKJptM4aQJuVZNW2WKiAeq8lBgj32WGy9wJ4-jj_KeNXaPwdLVpobFBtpAlgZnUvaRFYo6eX80mxMC1373ElsoIwL09yFD1_w3IaztSP1tybfs5ePC_gj8k9xvDkw5rTXlEbqlim9ypW1FebZN7dfyO1mVJj8nvsSmfpKWmk7KYn69Hvul4LVGyonWlIwVLko6-nI0_2W5ME4xN_4DnlYUZQKYoYeqb8InH1-f79OQK4B1g5oKezRaris4K2vYymf1SOR011eYUI8b0EJu69e4_xTIvkKjOKSuqD3RITzp6alqffVAQhx6ppbBbEpYn5OvB_unos900g7BlEDpL29O-8rXPmBIKjBDYYjRXMgZ8YoFgQZSrLPQc4QRZHjJfyzDKJdMs5rnQImMee0o2i7JQzwl1FVdRjp6Uo3wpc8EV2MF4_hpkyMVjkfeteqSyYUrHhh0XKXhMqElpp0kWedNNndf0IP-atIc61k1ARm9zoVx8TxuASLVSWsSB8qPc90PhCdiJpM_Bv8x0zIVjkXeooSniDggjRVM-AZ-EDF7pMARfCczfAMTf6c0EvJD94VZP0wavqvRaSS3yuhvGOzEHr1DlCueAMw57AGc3zIEXuNwDQ9oiz-pl0302iwIkv_QtEvUWVO9_6Y8Us3PDeI5pEmBpxi9ulv0luQuv9jFF0HV3yOZysVKvyG15uZxViwHZCKeh-Y0GZGtvf5IcD0wIZmBQA64l46Pk2x93W3j- |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9NAEF5VBQQS4iiXocCCQPBi1fau1zYSQiGlatQ0VDREfTPr9S6NVOyQoyj8KP4Sf4UZX40F6lsfeM2OnbE95-7MN4S8AAUTURJK24hE2Vx7vh05JrVNEErlpoKJopF21A8Gg_DoKDpYI7_qXhgsq6xtYmGo01zhHvkWK7DMnSAK302-2zg1Ck9X6xEapVjs6eUPSNlmb3vb8H1fet7Oh2F3166mCtjKD5y57RmuueGMaanBm4GtMkKrCASd-ZL5YaqTwHOk4ydpwLhRQZgqZlgkUmlkwhDoAEz-JQgjvLAoFTyoLb_ATLNEL2IscrZOcYQzGvyWzytGA_ztAFY8YLs6c8Xd7dz8317ULXKjCqxpp9SE22RNZxvkSjlqc7lBrpf7k7Rsu7pDfveK9lCaGzrIs8nx6s4-7a0Ugs5o2clJIVKm3Y-j3rbtRvQA996_wf3yrFhAJCxZ9G_hHT-d1S_QwyW4LzCjJ3Q0ni5mdJzRelbL-KdOabfqpqe4I077OLSudf0Q29iAo7JmLpu9oR162MBv0_JshwI7dF_PpV2DzNwlny_kbd8j61me6QeEulroMMVM0dFcqVQKDXE-ni_7CWINWeR1LY6xqpDgcSDJSQwZIUpu3EiuRZ43pJMS_uRfRO9RphsCRCwvfsinX-PKAMZGayMjX_Mw5TyQngRPq7iA_DkxkZCORV6hRsRoV4EZJav2EHgkRCiLOwHkghDe-8D-ZosS7KFqL9d6EVf2eBafKYVFnjXLeCXWGGY6XyCNy9HHCXYODfyBKzxIFCxyv1TT5rFZ6CO4J7dI2FLg1ntpr2Tj4wLRHctAIJKOHp7P-1NydXe434_7vcHeI3IN2OBYDum6m2R9Pl3ox-SyOp2PZ9MnhV2i5MtF6_cf28jRpA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zj9MwELZWyyEkxLFcgQUMAsFL1CR2nAQJodJSUW0pFbtU-xYcx2YrLUnpsaj8NP4Mf4WZHN1GoH3bB17jSTJx5vDYM98Q8gwUTERJKG0jEmVz7fl25JjUNkEolZsKJopC2vEgGA7Dw8NotEV-1bUwmFZZ28TCUKe5wj3yFiuwzJ0gClumSosYdXtvpt9t7CCFJ611O41SRPb06geEb_PX_S786-ee13t30HlvVx0GbOUHzsL2DNfccMa01ODZwG4ZoVUEQs98yfww1UngOdLxkzRg3KggTBUzLBKpNDJhCHoA5v9CgKDlRdrgqPYCAqPOEsmIschpnWA7ZzT-Df9XtAn42xlseMNmpuaG6-td_58n7Qa5Vi24abvUkJtkS2c75FLZgnO1Q66W-5a0LMe6RX73i7JRmhs6zLPp0eaOP-1vJIjOaVnhSWEFTTsfx_2u7UZ0hHvy3-B5eVYMIEKWLOq68ImfTvMa6P4K3BqY12M6nsyWczrJaN3DZfJTp7RTVdlT3CmnA2xm17j_AMvbgKMyly6bv6Jtur-G5ablmQ8FdugHvZB2DT5zm3w-l9m-Q7azPNP3CHW10GGKEaSjuVKpFBrW_3ju7CeIQWSRl7VoxqpCiMdGJccxRIooxfFaii3ydE06LWFR_kX0FuV7TYBI5sWFfPY1rgxjbLQ2MvI1D1POA-lJ8MCKC4irExMJ6VjkBWpHjPYWmFGyKhuBT0LksrgdQIwIy34f2N9tUIKdVM3hWkfiyk7P41MFsciT9TDeibmHmc6XSONy9H2CnUEDL3CFBwGERe6WKrv-bBb6CPrJLRI2lLkxL82RbHJUIL1jegissKP7Z_P-mFwGtY4H_eHeA3IFuOCYJem6u2R7MVvqh-SiOllM5rNHhYmi5Mt5q_cfHVPaYQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Nonpharmaceutical+Interventions+during+the+COVID-19+Pandemic+on+the+Prevalence+of+Respiratory+Syncytial+Virus+in+Hospitalized+Children+with+Lower+Respiratory+Tract+Infections%3A+A+Systematic+Review+and+Meta-Analysis&rft.jtitle=Viruses&rft.au=Leija-Mart%C3%ADnez%2C+Jos%C3%A9+J&rft.au=Esparza-Miranda%2C+Luis+A&rft.au=Rivera-Alfaro%2C+Gerardo&rft.au=Noyola%2C+Daniel+E&rft.date=2024-03-11&rft.issn=1999-4915&rft.eissn=1999-4915&rft.volume=16&rft.issue=3&rft_id=info:doi/10.3390%2Fv16030429&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon |